Machine learning-based predictive and risk analysis using real-world data with blood biomarkers for hepatitis B patients in the malignant progression of hepatocellular carcinoma

被引:5
|
作者
Nan, Yuemin [1 ]
Zhao, Suxian [1 ]
Zhang, Xiaoxiao [1 ]
Xiao, Zhifeng [2 ]
Guo, Ruihan [3 ]
机构
[1] Hebei Med Univ, Hosp 3, Dept Tradit & Western Med Hepatol, Hebei Prov Key Lab Liver Fibrosis Chron Liver Dis, Shijiazhuang, Peoples R China
[2] Behrend Coll, Sch Engn, Penn State Erie, Erie, PA USA
[3] Shanghai Ashermed Healthcare Co Ltd, Shanghai, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
hepatocellular carcinoma; blood biomarkers; machine learning; hepatitis B; cirrhosis; risk model; immunotherapy;
D O I
10.3389/fimmu.2022.1031400
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis B Virus (HBV) infection may lead to various liver diseases such as cirrhosis, end-stage liver complications, and Hepatocellular carcinoma (HCC). Patients with existing cirrhosis or severe fibrosis have an increased chance of developing HCC. Consequently, lifetime observation is currently advised. This study gathered real-world electronic health record (EHR) data from the China Registry of Hepatitis B (CR-HepB) database. A collection of 396 patients with HBV infection at different stages were obtained, including 1) patients with a sustained virological response (SVR), 2) patients with HBV chronic infection and without further development, 3) patients with cirrhosis, and 4) patients with HCC. Each patient has been monitored periodically, yielding multiple visit records, each is described using forty blood biomarkers. These records can be utilized to train predictive models. Specifically, we develop three machine learning (ML)-based models for three learning tasks, including 1) an SVR risk model for HBV patients via a survival analysis model, 2) a risk model to encode the progression from HBV, cirrhosis and HCC using dimension reduction and clustering techniques, and 3) a classifier to detect HCC using the visit records with high accuracy (over 95%). Our study shows the potential of offering a comprehensive understanding of HBV progression via predictive analysis and identifies the most indicative blood biomarkers, which may serve as biomarkers that can be used for immunotherapy.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] A Framework for Using Real-World Data and Health Outcomes Modeling to Evaluate Machine Learning-Based Risk Prediction Models
    Rodriguez, Patricia J.
    Veenstra, David L.
    Heagerty, Patrick J.
    Goss, Christopher H.
    Ramos, Kathleen J.
    Bansal, Aasthaa
    VALUE IN HEALTH, 2022, 25 (03) : 350 - 358
  • [2] Machine learning-based approach for glioblastoma drug repurposing on real-world patient data
    Lin, Ko-Hong
    Kim, Yejin
    Lee, Dung-Fang
    Jiang, Xiaoqian
    CANCER RESEARCH, 2023, 83 (08)
  • [3] A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
    Lee, Hye Won
    Kim, Hwiyoung
    Park, Taeyun
    Park, Soo Young
    Chon, Young Eun
    Seo, Yeon Seok
    Lee, Jae Seung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Kim, Seung Up
    LIVER INTERNATIONAL, 2023, 43 (08) : 1813 - 1821
  • [4] MACHINE LEARNING-BASED PREDICTION OF INPATIENT CARE COSTS FOR PATIENTS WITH BRAIN METASTASES: A REAL-WORLD ANALYSIS
    Ozair, Ahmad
    Chen, Chixiang
    Woodworth, Graeme
    Mukherjee, Debraj
    NEURO-ONCOLOGY, 2024, 26
  • [5] MACHINE LEARNING-BASED PREDICTION OF INPATIENT CARE COSTS FOR PATIENTS WITH BRAIN METASTASES: A REAL-WORLD ANALYSIS
    Ozair, A.
    Mukherjee, D.
    NEURO-ONCOLOGY, 2024, 26 : V59 - V60
  • [6] MACHINE LEARNING CAN ACCURATELY STRATIFY RISK OF HEPATOCELLULAR CARCINOMA IN REAL- WORLD DATA
    Clusmann, Jan
    Koop, Paul-Henry
    Zhang, David
    Van Haag, Felix
    El Nahhas, Omar
    Schneider, Kai Markus
    Kather, Jakob Nikolas
    Schneider, Carolin Victoria
    HEPATOLOGY, 2024, 80
  • [7] Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinoma
    Xiong, Ronghong
    Wang, Hui
    Li, Ying
    Zheng, Jingpeng
    Cheng, Yating
    Liu, Shunfang
    Yang, Guohua
    FRONTIERS IN GENETICS, 2022, 13
  • [8] Machine Learning-based Channel Prediction for Widely Distributed Massive MIMO with Real-World Data
    Loeschenbrand, David
    Hofer, Markus
    Eller, Lukas
    Rupp, Markus
    Zemen, Thomas
    FIFTY-SEVENTH ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS & COMPUTERS, IEEECONF, 2023, : 982 - 987
  • [9] Long-Term Survival and Risk Factors in Patients with Hepatitis B-Related Hepatocellular Carcinoma: A Real-World Study
    Zhu, Yu
    Gu, Ling-Ling
    Zhang, Fa-Biao
    Zheng, Guo-Qun
    Chen, Ting
    Jia, Wei-Dong
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 2022
  • [10] Evaluating generalizability of oncology trial results to real-world patients using machine learning-based trial emulations
    Orcutt, Xavier
    Chen, Kan
    Mamtani, Ronac
    Long, Qi
    Parikh, Ravi B.
    NATURE MEDICINE, 2025, 31 (02) : 457 - 465